418 related articles for article (PubMed ID: 11140914)
1. Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry.
Wang SA; Panlilio AL; Doi PA; White AD; Stek M; Saah A
Infect Control Hosp Epidemiol; 2000 Dec; 21(12):780-5. PubMed ID: 11140914
[TBL] [Abstract][Full Text] [Related]
2. Use of HIV Postexposure Prophylaxis in healthcare workers after occupational exposure: a Thai university hospital setting.
Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
J Med Assoc Thai; 2006 Jul; 89(7):974-8. PubMed ID: 16881429
[TBL] [Abstract][Full Text] [Related]
3. [Post-exposure prophylaxis of HIV infection in out-patient clinic of hospital for infectious diseases in Warsaw in 2001-2002].
Kowalska JD; Firlag-Burkacka E; Niezabitowska M; Bakowska E; Ignatowska A; Pulik P; Horban A
Przegl Epidemiol; 2006; 60(4):789-94. PubMed ID: 17682761
[TBL] [Abstract][Full Text] [Related]
4. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
[TBL] [Abstract][Full Text] [Related]
5. Significant intolerability of efavirenz in HIV occupational postexposure prophylaxis.
Wiboonchutikul S; Thientong V; Suttha P; Kowadisaiburana B; Manosuthi W
J Hosp Infect; 2016 Apr; 92(4):372-7. PubMed ID: 26876748
[TBL] [Abstract][Full Text] [Related]
6. The Danish PEP Registry: Experience with the use of post-exposure prophylaxis following blood exposure to HIV from 1999-2012.
Lunding S; Katzenstein TL; Kronborg G; Storgaard M; Pedersen C; Mørn B; Lindberg JÅ; Kronborg TM; Jensen J
Infect Dis (Lond); 2016; 48(3):195-200. PubMed ID: 26529586
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus postexposure prophylaxis for occupational exposure in a medical school hospital in Thailand.
Hiransuthikul N; Hiransuthikul P; Kanasuk Y
J Hosp Infect; 2007 Dec; 67(4):344-9. PubMed ID: 18023920
[TBL] [Abstract][Full Text] [Related]
8. Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana.
Tetteh RA; Nartey ET; Lartey M; Mantel-Teeuwisse AK; Leufkens HG; Nortey PA; Dodoo AN
BMC Public Health; 2015 Jun; 15():573. PubMed ID: 26092496
[TBL] [Abstract][Full Text] [Related]
9. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
U.S. Public Health Service
MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
Merchant RC; Keshavarz R
Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of HIV exposure and postexposure prophylaxis among health care workers in Greece.
Konte V; Nikolopoulos G; Raftopoulos V; Pylli M; Tsiara C; Makri E; Paraskeva D
Public Health Nurs; 2007; 24(4):337-42. PubMed ID: 17553023
[TBL] [Abstract][Full Text] [Related]
12. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus in traveling health care workers.
Uslan DZ; Virk A
J Travel Med; 2005; 12(1):14-8. PubMed ID: 15996462
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of rabies pre- and postexposure prophylaxis in 290 health-care-workers exposed to a rabies infected organ donor or transplant recipients.
Mattner F; Bitz F; Goedecke M; Viertel A; Kuhn S; Gastmeier P; Mattner L; Biertz F; Heim A; Henke-Gendo C; Engelmann I; Martens A; Strüber M; Schulz TF
Infection; 2007 Jun; 35(4):219-24. PubMed ID: 17646909
[TBL] [Abstract][Full Text] [Related]
14. Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus.
Luque A; Hulse S; Wang D; Shahzad U; Tanzman E; Antenozzi S; Smith B
Infect Control Hosp Epidemiol; 2007 Jun; 28(6):695-701. PubMed ID: 17520543
[TBL] [Abstract][Full Text] [Related]
15. Post exposure prophylaxis following occupational exposure to HIV: a survey of health care workers in Mbeya, Tanzania, 2009-2010.
Mponela MJ; Oleribe OO; Abade A; Kwesigabo G
Pan Afr Med J; 2015; 21():32. PubMed ID: 26405468
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.
Young TN; Arens FJ; Kennedy GE; Laurie JW; Rutherford Gw
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002835. PubMed ID: 17253483
[TBL] [Abstract][Full Text] [Related]
17. Understanding the magnitude of occupational exposure to human immunodeficiency virus (HIV) and uptake of HIV post-exposure prophylaxis among healthcare workers in a rural district in Tanzania.
Mabwe P; Kessy AT; Semali I
J Hosp Infect; 2017 Jul; 96(3):276-280. PubMed ID: 28274607
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV.
Lee LM; Henderson DK
Drug Saf; 2001; 24(8):587-97. PubMed ID: 11480491
[TBL] [Abstract][Full Text] [Related]
19. Zidovudine toxicity in uninfected healthcare workers. Italian Registry of Antiretroviral Prophylaxis.
Ippolito G; Puro V
Am J Med; 1997 May; 102(5B):58-62. PubMed ID: 9845498
[TBL] [Abstract][Full Text] [Related]
20. Registry finds 3 drugs most favored PEP regimen.
AIDS Alert; 1998 Jul; 13(7):75-6. PubMed ID: 11365586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
